PGEN
Overvalued by 103.7% based on the discounted cash flow analysis.
Market cap | $353.39 Million |
---|---|
Enterprise Value | $308.63 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-0.39 |
Beta | 2.09 |
Outstanding Shares | 252,419,690 |
Avg 30 Day Volume | 745,845 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -3.65 |
---|---|
PEG | -82.57 |
Price to Sales | - |
Price to Book Ratio | - |
Enterprise Value to Revenue | 56.74 |
Enterprise Value to EBIT | -3.43 |
Enterprise Value to Net Income | -4 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data